Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-03-14 @ 5:28 AM
Study NCT ID:
NCT03461627
Status:
UNKNOWN
Last Update Posted:
2018-03-12
First Post:
2017-12-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-12-28
First Submit QC Date:
None
Study First Post Date:
2018-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-05
Last Update Post Date:
2018-03-12
Last Update Post Date Type:
ACTUAL